Literature DB >> 27362742

Chronic fatigue syndrome - an update.

Steven Rimbaut1, Céline Van Gutte1, Lina Van Brabander1, Luc Vanden Bossche1.   

Abstract

BACKGROUND: Chronic fatigue syndrome is a widespread condition with a huge impact not only on a patient's life, but also on society as evidenced by substantial losses of productivity, informal costs, and medical expenses. The high prevalence rates (0.2-6.4%) and the low employment rates (27-41%) are responsible for the enormous burden imposed on society, with loss of productivity representing the highest cost. The objective of this review is to systematically review the recent literature on chronic fatigue syndrome/myalgic encephalomyelitis.
METHODS: The published literature between 1 January 1990 and 1 April 2015 was searched using the MEDLINE, Cochrane Library, and Web of Sciences databases. The reference lists of the selected articles were screened for other relevant articles. RESULTS AND
CONCLUSIONS: Despite extensive research, none of the proposed etiological factors have shown strong, reproducible scientific evidence. Over the years, the biopsychosocial model integrating many of the proposed hypotheses has been gaining popularity over the biomedical model, where the focus is on one physical cause. Since the etiological mechanism underlying chronic fatigue syndrome is currently unknown, disease-specific treatments do not exist. Various treatments have been investigated but only cognitive behavior therapy (CBT) and graded exercise therapy (GET) have shown moderate effectiveness.

Entities:  

Keywords:  Chronic fatigue syndrome; Cost of care; Evidence based medicine; Exercise/activity; Physiotherapy; Systematic review

Year:  2016        PMID: 27362742     DOI: 10.1080/17843286.2016.1196862

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  6 in total

1.  Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.

Authors:  Christina Mueller; Joanne C Lin; Sulaiman Sheriff; Andrew A Maudsley; Jarred W Younger
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

2.  The Relationship Between Childhood Trauma and the Response to Group Cognitive-Behavioural Therapy for Chronic Fatigue Syndrome.

Authors:  Maud De Venter; Jela Illegems; Rita Van Royen; Bernard G C Sabbe; Greta Moorkens; Filip Van Den Eede
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

3.  Predicting GP visits: A multinomial logistic regression investigating GP visits amongst a cohort of UK patients living with Myalgic encephalomyelitis.

Authors:  R Stephen Walsh; Andrew Denovan; Kenneth Drinkwater; Sean Reddington; Neil Dagnall
Journal:  BMC Fam Pract       Date:  2020-06-10       Impact factor: 2.497

4.  Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety.

Authors:  Jo Daniels; Hannah Parker; Paul Martin Salkovskis
Journal:  Int J Clin Health Psychol       Date:  2019-12-24

5.  Irritable bowel, chronic widespread pain, chronic fatigue and related syndromes are prevalent and highly overlapping in the general population: DanFunD.

Authors:  Marie Weinreich Petersen; Andreas Schröder; Torben Jørgensen; Eva Ørnbøl; Thomas Meinertz Dantoft; Marie Eliasen; Michael Eriksen Benros; Per Fink
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

6.  Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study.

Authors:  N Eaton-Fitch; S C Johnston; P Zalewski; D Staines; S Marshall-Gradisnik
Journal:  Qual Life Res       Date:  2020-01-22       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.